Lv11
60 积分 2024-06-23 加入
Proton pump inhibitors and the risk of inflammatory bowel disease: a Mendelian randomisation study
2小时前
已完结
The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis of randomised controlled studies
16天前
已完结
Increased incidence of GERD in GLP-1 treated patients: fact or artefact?
21天前
已完结
Proton pump inhibitors and the risk of inflammatory bowel disease: population-based cohort study
22天前
已完结
Concerns about instrumental variable selection for biological effect versus uptake of proton pump inhibitors in Mendelian randomisation analysis
1个月前
已完结
Symptomatic Response to Omeprazole in Inflammatory Bowel Disease
1个月前
已完结
Proton pump inhibitors and the risk of inflammatory bowel disease: cause, protopathic bias or others?
1个月前
已完结
Proton pump inhibitors and the risk of inflammatory bowel disease: a Mendelian randomisation study
1个月前
已完结
Pathway Analysis for Targeted and Untargeted Metabolomics
2个月前
已完结
Heart failure with preserved ejection fraction: everything the clinician needs to know
3个月前
已完结
皖公网安备34019202002308
